Biobanking Market Analysis BY Biobank Type (Population-Based Biobanks, Disease-Based Biobanks, Virtual Biobanks), By Sample Type (Human Tissues, Stem Cells, Other Biological Samples), By Application (Therapeutics, Research, Clinical Trials), By Storage Type (Manual Storage Systems, Automated Storage Systems), By End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Hospitals and Diagnostic Laboratories) and by Region: Global Forecast, 2024 - 2034.
- PUBLISHED ON
- 2024-05-25
- NO OF PAGES
- 249
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Biobanking market is predicted to
develop at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, when
it is projected to reach USD 184.28 Billion, based on an average growth pattern.
The market is estimated to reach a value of USD 81.50 Billion in 2024.
SOURCE: We Market Research
Biobanking is
the process of gathering, preserving, and handling biological samples—such as
blood and tissue—for scientific and medical purposes. These samples, along with
comprehensive information about the donors' health, are kept under particular
circumstances to ensure their survival. To ensure donor anonymity, biobanks
must adhere to stringent ethical and regulatory criteria. They contribute to
the advancement of genetics, disease treatments, and personalised medicine
research by supporting it. In order to support biomedical research and enhance
patient outcomes, biobanks are crucial sources of high-quality, thoroughly
recorded samples.
The growing incidence of chronic illnesses, technological developments in sample management and storage, and developments in biomedical research are the main factors driving the worldwide biobanking industry. Infrastructure and research projects are supported by increased public and private funding. Large-scale population studies and growing applications in stem cell and regenerative medicine are driving up demand for biobanked samples. Participation is encouraged by ethical and legal frameworks that guarantee donor confidentiality and the use of samples. Through facilitating data sharing and speeding up scientific discoveries, collaborative research projects between institutions, healthcare providers, and biobanks further fuel market growth.
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 81.50 Billion |
|
Market Forecast in 2034 |
USD 184.28 Billion |
|
CAGR % 2024-2034 |
8.5% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
BY Biobank Type, By Sample Type, By Application, By Storage Type, By End
User and By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Biobanking Industry: Dynamics & Restrains
Market opportunity:
We Market
Research: Biobanking Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Biobanking Segmentation
Market- By Biobank Type Analysis
By Biobank Type, the Biobanking Market is Categories into Population-Based Biobanks, Disease-Based Biobanks, Virtual Biobanks. The Disease-Based Biobanks segment accounts for the largest share of around 48% in 2024.
The driver for Disease-Based Biobanks is
the growing prevalence of chronic diseases and the need for personalized
medicine, which necessitates extensive data on disease-specific genetic and
molecular profiles to develop targeted treatments and improve patient outcomes.
The
following segments are part of an in-depth analysis of the global Biobanking
market:
|
Market Segments |
|
|
By Sample Type |
·
Human Tissues ·
Stem Cells ·
Other Biological Samples |
|
By Application |
·
Therapeutics ·
Research ·
Clinical Trials |
|
By Storage Type |
·
Manual Storage Systems ·
Automated Storage Systems |
|
By End User |
·
Pharmaceutical and
Biotechnology Companies ·
Academic Research Institutes ·
Hospitals and Diagnostic
Laboratories |
Biobanking Industry: Regional Analysis
North America Market Forecast
North America dominate the Biobanking Market with the highest revenue generating market with share of more than 47%. Leading biobanking companies, robust government support, and advances in personalized medicine foster growth. Extensive R&D activities and a high prevalence of chronic diseases also contribute to the market's expansion.
Europe Market Statistics
Europe’s
biobanking market thrives due to its robust regulatory frameworks, strong
healthcare systems, and substantial research funding. The region's
collaborative research initiatives and cross-border projects enhance biobank
operations and data sharing. Supportive policies and funding for innovative
research drive the growth and efficiency of biobanks across Europe.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Biobanking market
during the forecast period. The Asia-Pacific market is expanding rapidly due to
economic growth, increased healthcare investments, and a focus on personalized
medicine. The region benefits from growing patient populations and improving
healthcare infrastructure. Governments and private entities are investing in
biobanking, enhancing research capabilities and the availability of biological
samples for studies.
Key Market Players
The Biobanking
Market is dominated by a few large companies, such as
·
Thermo Fisher Scientific Inc.
·
PHC Holdings Corporation
·
Becton, Dickinson and Company
·
QIAGEN N.V.
·
Merck KGaA
·
Sampled
·
Avantor, Inc.
·
Cryoport, Inc.
·
Tecan Trading AG
·
Azenta, Inc.
·
Greiner Holding AG
· Others
1.
Global
Biobanking Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Biobanking Market Scope
and Market Estimation
1.2.1.Global Biobanking Overall Market
Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2.Global Biobanking Market Revenue
Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1.Biobank Type of Global Biobanking
Market
1.3.2.Sample Type of Global Biobanking
Market
1.3.3.Application of Global Biobanking
Market
1.3.4.Storage Type of Global Biobanking
Market
1.3.5.End User of Global Biobanking
Market
1.3.6.Region of Global Biobanking
Market
2.
Executive Summary
2.1. Market Dynamics
2.1.1.Drivers
2.1.2.Limitations
2.1.3.Opportunities
2.1.4.Impact Analysis of Drivers and
Restraints
2.2. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.3. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.4. Porter’s Five Forces Analysis
2.4.1.Bargaining Power of Suppliers
2.4.2.Bargaining Power of Buyers
2.4.3.Threat of Substitutes
2.4.4.Threat of New Entrants
2.4.5.Competitive Rivalry
2.5. Value Chain / Ecosystem Analysis
2.6. Russia-Ukraine War Impacts
Analysis
2.7. Economic Downturn Analysis
2.8. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Biobanking Market Estimates & Historical Trend Analysis (2019 -
2023)
4.
Global Biobanking Market Estimates & Forecast Trend Analysis, by
Biobank Type
4.1. Global Biobanking Market Revenue
(US$ Mn) Estimates and Forecasts, by Biobank Type, 2019 to 2034
4.1.1.Population-Based Biobanks
4.1.2.Disease-Based Biobanks
4.1.3.Virtual Biobanks
5.
Global Biobanking Market Estimates & Forecast Trend Analysis, by
Sample Type
5.1. Global Biobanking Market Revenue
(US$ Mn) Estimates and Forecasts, by Sample Type, 2019 to 2034
5.1.1.Human Tissues
5.1.2.Stem Cells
5.1.3.Other Biological Samples
6.
Global Biobanking Market Estimates & Forecast Trend Analysis, by
Application
6.1. Global Biobanking Market Revenue
(US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
6.1.1.Therapeutics
6.1.2.Research
6.1.3.Clinical Trials
7.
Global Biobanking Market Estimates & Forecast Trend Analysis, by
Storage Type
7.1. Global Biobanking Market Revenue
(US$ Mn) Estimates and Forecasts, by Storage Type, 2019 to 2034
7.1.1.Manual Storage Systems
7.1.2.Automated Storage Systems
8.
Global Biobanking Market Estimates & Forecast Trend Analysis, by
End User
8.1. Global Biobanking Market Revenue
(US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034
8.1.1.Pharmaceutical and Biotechnology
Companies
8.1.2.Academic Research Institutes
8.1.3.Hospitals and Diagnostic
Laboratories
9.
Global Biobanking Market Estimates & Forecast Trend Analysis,
by Region
9.1. Global Biobanking Market Revenue
(US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
9.1.1.North America
9.1.2.Europe
9.1.3.Asia Pacific
9.1.4.Middle East & Africa
9.1.5.South America
10. North America Biobanking
Market: Estimates & Forecast Trend
Analysis
10.1.
North
America Biobanking Market Assessments & Key Findings
10.1.1. North America Biobanking Market
Introduction
10.1.2. North America Biobanking Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1. By Biobank Type
10.1.2.2. By Sample Type
10.1.2.3. By Application
10.1.2.4. By Storage Type
10.1.2.5. By End User
10.1.2.6. By Country
10.1.2.6.1. The U.S.
10.1.2.6.2. Canada
10.1.2.6.3. Mexico
11. Europe Biobanking
Market: Estimates & Forecast Trend
Analysis
11.1. Europe Biobanking Market
Assessments & Key Findings
11.1.1. Europe Biobanking Market
Introduction
11.1.2. Europe Biobanking Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1. By Biobank Type
11.1.2.2. By Sample Type
11.1.2.3. By Application
11.1.2.4. By Storage Type
11.1.2.5. By End User
11.1.2.6. By Country
11.1.2.6.1. Germany
11.1.2.6.2. U.K.
11.1.2.6.3. France
11.1.2.6.4. Italy
11.1.2.6.5. Spain
11.1.2.6.6. Russia
11.1.2.6.7. Rest of Europe
12. Asia Pacific Biobanking
Market: Estimates & Forecast Trend
Analysis
12.1. Asia Pacific Market Assessments
& Key Findings
12.1.1. Asia Pacific Biobanking Market
Introduction
12.1.2. Asia Pacific Biobanking Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1. By Biobank Type
12.1.2.2. By Sample Type
12.1.2.3. By Application
12.1.2.4. By Storage Type
12.1.2.5. By End User
12.1.2.6. By Country
12.1.2.6.1. China
12.1.2.6.2. Japan
12.1.2.6.3. India
12.1.2.6.4. Australia
12.1.2.6.5. South Korea
12.1.2.6.6. ASEAN
12.1.2.6.7. Rest of Asia Pacific
13. Middle East & Africa Biobanking
Market: Estimates & Forecast Trend
Analysis
13.1. Middle East & Africa Market
Assessments & Key Findings
13.1.1. Middle
East & Africa Biobanking
Market Introduction
13.1.2. Middle
East & Africa Biobanking
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
13.1.2.1. By Biobank Type
13.1.2.2. By Sample Type
13.1.2.3. By Application
13.1.2.4. By Storage Type
13.1.2.5. By End User
13.1.2.6. By Country
13.1.2.6.1. U.A.E.
13.1.2.6.2. Saudi Arabia
13.1.2.6.3. Egypt
13.1.2.6.4. South Africa
13.1.2.6.5. Rest of Middle East & Africa
14. South America
Biobanking Market: Estimates & Forecast
Trend Analysis
14.1. South America Market Assessments
& Key Findings
14.1.1. South America Biobanking Market
Introduction
14.1.2. South America Biobanking Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
14.1.2.1. By Biobank Type
14.1.2.2. By Sample Type
14.1.2.3. By Application
14.1.2.4. By Storage Type
14.1.2.5. By End User
14.1.2.6. By Country
14.1.2.6.1. Brazil
14.1.2.6.2. Argentina
14.1.2.6.3. Colombia
14.1.2.6.4. Rest of South America
15. Competition Landscape
15.1. Global Biobanking Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
15.2. Global Biobanking Market
Competition White Space Analysis, By End-user
15.3. Global Biobanking Market
Competition Heat Map Analysis, By End-user
15.4. Global Biobanking Market
Concentration & Company Market Shares (%) Analysis, 2022
16. Company Profiles
16.1.
Thermo Fisher Scientific Inc.
16.1.1. Company Overview & Key Stats
16.1.2. Financial Performance & KPIs
16.1.3. Product Portfolio
16.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
16.2. PHC Holdings
Corporation
16.3. Becton,
Dickinson and Company
16.4. QIAGEN N.V.
16.5. Merck KGaA
16.6. Sampled
16.7. Avantor, Inc.
16.8. Cryoport, Inc.
16.9. Tecan Trading
AG
16.10. Azenta, Inc.
16.11. Greiner
Holding AG
16.12. Others
17. Research
Methodology
17.1. External Transportations /
Databases
17.2. Internal Proprietary Database
17.3. Primary Research
17.4. Secondary Research
17.5. Assumptions
17.6. Limitations
17.7. Report FAQs
18. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Biobanking Market in 2024?
Biobanking Market was valued at USD 81.50 Billion in 2024.
What is the growth rate for the Biobanking Market?
Biobanking Market size will increase at approximate CAGR of 8.5% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Biobanking Market Are Thermo Fisher Scientific Inc., PHC Holdings Corporation, Becton, Dickinson and Company, QIAGEN N.V., Merck KGaA, Sampled, Avantor, Inc., Cryoport, Inc., Tecan Trading AG, Azenta, Inc., Greiner Holding AG and Others.
Which region dominates the Biobanking Market?
North America dominates the market with an active share of 47%.
}})
Select a license type that suits your business needs
US $3499
Only Three Thousand Four Hundred Ninety Nine US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4499
Only Four Thousand Four Hundred Ninety Nine US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5499
Only Five Thousand Four Hundred Ninety Nine US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI